> Details

Zwingenberger, Stefan; Langanke, Robert; Vater, Corina; Lee, Geoffrey; Niederlohmann, Eik; Sensenschmidt, Markus; Jacobi, Angela; Bernhardt, Ricardo; Muders, Michael; Rammelt, Stefan; Knaack, Sven; Gelinsky, Michael; Günther, Klaus‐Peter; Goodman, Stuart B.; Stiehler, Maik

The effect of SDF‐1α on low dose BMP‐2 mediated bone regeneration by release from heparinized mineralized collagen type I matrix scaffolds in a murine critical size bone defect model

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: The effect of SDF‐1α on low dose BMP‐2 mediated bone regeneration by release from heparinized mineralized collagen type I matrix scaffolds in a murine critical size bone defect model
  • Contributor: Zwingenberger, Stefan; Langanke, Robert; Vater, Corina; Lee, Geoffrey; Niederlohmann, Eik; Sensenschmidt, Markus; Jacobi, Angela; Bernhardt, Ricardo; Muders, Michael; Rammelt, Stefan; Knaack, Sven; Gelinsky, Michael; Günther, Klaus‐Peter; Goodman, Stuart B.; Stiehler, Maik
  • Published: Wiley, 2016
  • Published in: Journal of Biomedical Materials Research Part A, 104 (2016) 9, Seite 2126-2134
  • Language: English
  • DOI: 10.1002/jbm.a.35744
  • ISSN: 1549-3296; 1552-4965
  • Origination:
  • Footnote:
  • Description: AbstractThe treatment of critical size bone defects represents a challenge. The growth factor bone morphogenetic protein 2 (BMP‐2) is clinically established but has potentially adverse effects when used at high doses. The aim of this study was to evaluate if stromal derived factor‐1 alpha (SDF‐1α) and BMP‐2 released from heparinized mineralized collagen type I matrix (MCM) scaffolds have a cumulative effect on bone regeneration. MCM scaffolds were functionalized with heparin, loaded with BMP‐2 and/or SDF‐1α and implanted into a murine critical size femoral bone defect (control group, low dose BMP‐2 group, low dose BMP‐2 + SDF‐1α group, and high dose BMP‐2 group). After 6 weeks, both the low dose BMP‐2 + SDF‐1α group (5.8 ± 0.6 mm³, p = 0.0479) and the high dose BMP‐2 group (6.5 ± 0.7 mm³, p = 0.008) had a significantly increased regenerated bone volume compared to the control group (4.2 ± 0.5 mm³). There was a higher healing score in the low dose BMP‐2 + SDF‐1α group (median grade 8; Q1‐Q3 7‐9; p = 0.0357) than in the low dose BMP‐2 group (7; Q1‐Q3 5‐9) histologically. This study showed that release of BMP‐2 and SDF‐1α from heparinized MCM scaffolds allows for the reduction of the applied BMP‐2 concentration since SDF‐1α seems to enhance the osteoinductive potential of BMP‐2. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 2126–2134, 2016.